OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: OXB) (the ...

Ltd, and Westlake Laboratory of Life Sciences and Biomedicine report a pre-clinical study that evaluates the safety and efficacy of SIN-IL2RG-LV vector-based gene therapy for X-SCID. Using next ...

vector, which is administered into the eye by intravitreal injection and is designed to restore the function of retinal cells. In RESTORE, a once-off administration of the gene therapy led to a ...

The plasmid was transfected with Lipofectamine 2000 ... which is helpful in delivering genes based on SINV vector. In further study, the vectors based on SINV may be used for oncolytic therapy. At the ...

It also bought an option on a liver disease therapy developed by Vivet Therapeutics and bought Bamboo Therapeutics to provide a viral vector platform for gene therapy delivery and early-stage ...

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders. Now it’s on the cusp of its first regulatory approval. Each year ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in ...

Tomas has become the first in the world to be treated with a new gene therapy (Handout/PA) A baby boy with a rare illness is making “incredible” progress after he became the first ever patient ...